| 1 | Patients | 2.52% | |
| 2 | ASCO | 2.52% | |
| 3 | Status | 1.89% | |
| 4 | Checkpoint | 1.26% | |
| 5 | Immune | 1.26% | |
| 6 | Outcomes | 1.26% | |
| 7 | mCRPC | 1.26% | |
| 8 | Protein | 1.26% | |
| 9 | Number | 1.26% | |
| 10 | According | 1.26% | |
| 11 | Cardiovascular | 1.26% | |
| 12 | Versus | 1.26% | |
| 13 | Tumor | 1.26% | |
| 14 | Use | 1.26% | |
| 15 | Disease | 1.26% | |
| 16 | Septic | 0.63% | |
| 17 | Prostatitis | 0.63% | |
| 18 | Tissue | 0.63% | |
| 19 | Clinical | 0.63% | |
| 20 | Caused | 0.63% | |
| 21 | Strategies | 0.63% | |
| 22 | Signs | 0.63% | |
| 23 | Deaths | 0.63% | |
| 24 | Effectiveness | 0.63% | |
| 25 | Risk | 0.63% | |
| 26 | Burden | 0.63% | |
| 27 | Syndrome | 0.63% | |
| 28 | Biomarkers | 0.63% | |
| 29 | Study | 0.63% | |
| 30 | Durvalumab | 0.63% | |
| 31 | Spacer | 0.63% | |
| 32 | Value | 0.63% | |
| 33 | Inhibitor | 0.63% | |
| 34 | Endosteal | 0.63% | |
| 35 | UT | 0.63% | |
| 36 | Somatic | 0.63% | |
| 37 | DME | 0.63% | |
| 38 | Sugar | 0.63% | |
| 39 | Carcinoma | 0.63% | |
| 40 | Part | 0.63% | |
| 41 | Placement | 0.63% | |
| 42 | Night | 0.63% | |
| 43 | Microsatellite | 0.63% | |
| 44 | Utility | 0.63% | |
| 45 | Are | 0.63% | |
| 46 | New | 0.63% | |
| 47 | Severe | 0.63% | |
| 48 | Choice | 0.63% | |
| 49 | Mutation | 0.63% | |
| 50 | Perioperative | 0.63% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||